102 related articles for article (PubMed ID: 26371559)
21. The role of a single nucleotide polymorphism of MDM2 in glioblastoma multiforme.
Khatri RG; Navaratne K; Weil RJ
J Neurosurg; 2008 Nov; 109(5):842-8. PubMed ID: 18976073
[TBL] [Abstract][Full Text] [Related]
22. Clinical implications of the MDM2 SNP309 and p53 Arg72Pro polymorphisms in transitional cell carcinoma of the bladder.
Horikawa Y; Nadaoka J; Saito M; Kumazawa T; Inoue T; Yuasa T; Tsuchiya N; Nishiyama H; Ogawa O; Habuchi T
Oncol Rep; 2008 Jul; 20(1):49-55. PubMed ID: 18575717
[TBL] [Abstract][Full Text] [Related]
23. MDM2 SNP309 contributes to tumor susceptibility: a meta-analysis.
Wo X; Han D; Sun H; Liu Y; Meng X; Bai J; Chen F; Yu Y; Jin Y; Fu S
J Genet Genomics; 2011 Aug; 38(8):341-50. PubMed ID: 21867960
[TBL] [Abstract][Full Text] [Related]
24. Association between SNP309 and del1518 Polymorphism in MDM2 Homologue and Esophageal Squamous Cell Carcinoma Risk in Chinese Population of Shandong Province.
Zhang L; Zhu Z; Wu H; Wang K
Ann Clin Lab Sci; 2015; 45(4):433-7. PubMed ID: 26275695
[TBL] [Abstract][Full Text] [Related]
25. Dysplastic Changes in Patients with Recurrent Laryngeal Leukoplakia: Importance of Long-Term Follow-Up.
Jabarin B; Pitaro J; Marom T; Muallem-Kalmovich L
Isr Med Assoc J; 2018 Oct; 20(10):623-626. PubMed ID: 30324779
[TBL] [Abstract][Full Text] [Related]
26. [Clinical analyses of 263 patients with laryngeal leukoplakia].
Niu YY; Wang J; Huo H; Jin XF; Li WY; Gao ZQ
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Aug; 53(8):575-580. PubMed ID: 30121994
[No Abstract] [Full Text] [Related]
27. Helicobacter pylori infection and MDM2 SNP309 association with gastric cancer susceptibility.
Moradi MT; Salehi Z; Asl SF; Aminian K; Hashtchin AR
Genet Test Mol Biomarkers; 2013 Nov; 17(11):794-8. PubMed ID: 24010568
[TBL] [Abstract][Full Text] [Related]
28. Association of the germline TP53 R72P and MDM2 SNP309 variants with breast cancer survival in specific breast tumor subgroups.
van den Broek AJ; Broeks A; Horlings HM; Canisius SV; Braaf LM; Langerød A; Van't Veer LJ; Schmidt MK
Breast Cancer Res Treat; 2011 Nov; 130(2):599-608. PubMed ID: 21667122
[TBL] [Abstract][Full Text] [Related]
29. Expression and significance of p53 and mdm2 in patients with leukoplakia cancer.
Cui JJ; Han XL; Wang WM
Asian Pac J Trop Med; 2013 Oct; 6(10):831-4. PubMed ID: 23870475
[TBL] [Abstract][Full Text] [Related]
30. MDM2 SNP309 is associated with poor outcome in B-cell chronic lymphocytic leukemia.
Gryshchenko I; Hofbauer S; Stoecher M; Daniel PT; Steurer M; Gaiger A; Eigenberger K; Greil R; Tinhofer I
J Clin Oncol; 2008 May; 26(14):2252-7. PubMed ID: 18467716
[TBL] [Abstract][Full Text] [Related]
31. Distribution and Effects of CDKN2 p16 540 C>G and 580 C>T, and MDM2 SNP309 T>G Polymorphisms in Patients with Primary Brain Tumors.
Kafadar A; Küçükhüseyin Ö; Turan S; Yenilmez EN; Tunoglu S; Zeybek U; Kaynar MY; Kemerdere R; Yaylim I
Anticancer Res; 2015 Jul; 35(7):3933-42. PubMed ID: 26124340
[TBL] [Abstract][Full Text] [Related]
32. MDM2 SNP309 genotype influences survival of metastatic but not of localized neuroblastoma.
Perfumo C; Parodi S; Mazzocco K; Defferrari R; Inga A; Scarrà GB; Ghiorzo P; Haupt R; Tonini GP; Fronza G
Pediatr Blood Cancer; 2009 Oct; 53(4):576-83. PubMed ID: 19526525
[TBL] [Abstract][Full Text] [Related]
33. Impact of MDM2 polymorphism: increased risk of developing colorectal cancer and a poor prognosis in the Tunisian population.
Chaar I; Arfaoui TA; El Amine el HO; Mahmoud LB; Khiari M; Sammoud S; Lounis A; Amara S; Gharbi L; Hmida AB; Mzabi S; Bouraoui S
Eur J Gastroenterol Hepatol; 2012 Mar; 24(3):320-7. PubMed ID: 22266832
[TBL] [Abstract][Full Text] [Related]
34. Clinicopathological parameters associated with histological background and recurrence after surgical intervention of vocal cord leukoplakia.
Cui W; Xu W; Yang Q; Hu R
Medicine (Baltimore); 2017 Jun; 96(22):e7033. PubMed ID: 28562558
[TBL] [Abstract][Full Text] [Related]
35. Genetic polymorphisms of MDM2, cumulative cigarette smoking and nonsmall cell lung cancer risk.
Liu G; Wheatley-Price P; Zhou W; Park S; Heist RS; Asomaning K; Wain JC; Lynch TJ; Su L; Christiani DC
Int J Cancer; 2008 Feb; 122(4):915-8. PubMed ID: 17957785
[TBL] [Abstract][Full Text] [Related]
36. The Role of
Turgut S; Ilhan M; Turan S; Karaman O; Yaylim I; Kucukhuseyin O; Tasan E
In Vivo; 2017; 31(3):357-363. PubMed ID: 28438863
[TBL] [Abstract][Full Text] [Related]
37. MDM2 SNP309T>G polymorphism and risk of hepatocellular carcinoma: a case-control analysis in a Moroccan population.
Ezzikouri S; El Feydi AE; Afifi R; El Kihal L; Benazzouz M; Hassar M; Marchio A; Pineau P; Benjelloun S
Cancer Detect Prev; 2009; 32(5-6):380-5. PubMed ID: 19233569
[TBL] [Abstract][Full Text] [Related]
38. Genotypic interaction and gender specificity of common genetic variants in the p53/mdm2 network in Crohn's disease.
Zimmer V; Widmann T; Müller M; Ong MF; Stein JM; Pfreundschuh M; Lammert F; Roemer K; Assmann G
Digestion; 2010; 81(4):246-51. PubMed ID: 20110711
[TBL] [Abstract][Full Text] [Related]
39. The MDM2 309 T/G polymorphism is associated with head and neck cancer risk especially in nasopharyngeal cancer: a meta-analysis.
Zhang Y; Bai Y; Zhang Y; Guan J; Chen L
Onkologie; 2012; 35(11):666-70. PubMed ID: 23147543
[TBL] [Abstract][Full Text] [Related]
40. TP53 mutations and MDM2(SNP309) identify subgroups of AML patients with impaired outcome.
Falk IJ; Willander K; Chaireti R; Lund J; Nahi H; Hermanson M; Gréen H; Lotfi K; Söderkvist P
Eur J Haematol; 2015 Apr; 94(4):355-62. PubMed ID: 25156865
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
